Skip to content

Venaflo® II ePTFE Vascular Grafts VLT4046CRecalls & reported problems

Bard Peripheral Vascular, Inc. · Venaflo® II ePTFE Vascular Graft WITH CARBON STEPPED, 4-6 mm x 40 cm · Class 2 · Implant

All models of Venaflo II ePTFE Vascular Grafts (9)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00801741020582), received between Mar 23, 2020 and Aug 26, 2020 — classified as 5 injuries.

The most frequently reported specific device problem is “Leak/Splash” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Leak/Splash4
  • Obstruction of Flow1

Patient problems

  • Unspecified Infection4
  • Swelling1
  • Thrombus1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 26, 2020Obstruction of Flow; Obstruction of Flow

    IT WAS REPORTED ONE DAY POST VASCULAR GRAFT PLACEMENT, THERE WAS NO MURMUR OR TREMOR. ULTRASOUND DEMONSTRATED THROMBI WITHIN THE GRAFT AND THE GRAFT WAS REMOVED AND REVEALED A COLLAPSED LUMEN. A NEW GRAFT WAS PLACED AND BLOOD FLOW WAS RESTORED. THE CURRENT PATIENT STATUS WAS NOT PROVIDED.

    Patient problems: Swelling; Thrombus

    MAUDE report 10453738 ↗
  • InjuryMar 23, 2020Leak/Splash; Leak/Splash

    IT WAS REPORTED THAT POST-SURGICAL GRAFT IMPLANTATION IN AVF, THE SURGICAL GRAFT LEAKED FLUID AND THE PATIENT EXPERIENCED INFECTION WITHIN THE HOSPITAL. IT WAS FURTHER REPORTED THAT THE INFECTION WAS TREATED FOR TWO WEEKS WITH ANTIBIOTICS AND THAT THE SURGICAL GRAFT WILL REMAIN IMPLANTED. THE HEALTHCARE PROVIDER (HCP) WILL CONTINUE TO OBSERVE THE PATIENT'S SYMPTOMS. THE PATIENT IS REPORTEDLY STABLE.

    Patient problems: Unspecified Infection

    MAUDE report 9869368 ↗
  • InjuryMar 23, 2020Leak/Splash; Leak/Splash

    IT WAS REPORTED THAT POST-SURGICAL GRAFT IMPLANTATION IN AVF, THE SURGICAL GRAFT LEAKED FLUID AND THE PATIENT EXPERIENCED INFECTION WITHIN THE HOSPITAL. IT WAS FURTHER REPORTED THAT THE INFECTION WAS TREATED FOR TWO WEEKS WITH ANTIBIOTICS AND THAT THE SURGICAL GRAFT WILL REMAIN IMPLANTED. THE HEALTHCARE PROVIDER (HCP) WILL CONTINUE TO OBSERVE THE PATIENT'S SYMPTOMS. THE PATIENT IS REPORTEDLY STABLE.

    Patient problems: Unspecified Infection

    MAUDE report 9869204 ↗
  • InjuryMar 23, 2020Leak/Splash; Leak/Splash

    IT WAS REPORTED THAT POST-SURGICAL GRAFT IMPLANTATION IN AVF, THE SURGICAL GRAFT LEAKED FLUID AND THE PATIENT EXPERIENCED INFECTION WITHIN THE HOSPITAL. IT WAS FURTHER REPORTED THAT THE INFECTION WAS TREATED FOR TWO WEEKS WITH ANTIBIOTICS AND THAT THE SURGICAL GRAFT WILL REMAIN IMPLANTED. THE PATIENT IS REPORTED AS STABLE.

    Patient problems: Unspecified Infection

    MAUDE report 9869181 ↗
  • InjuryMar 23, 2020Leak/Splash; Leak/Splash

    IT WAS REPORTED THAT POST-SURGICAL GRAFT IMPLANTATION IN AVF, THE SURGICAL GRAFT LEAKED FLUID AND THE PATIENT EXPERIENCED INFECTION WITHIN THE HOSPITAL. IT WAS FURTHER REPORTED THAT THE INFECTION WAS TREATED FOR TWO WEEKS WITH ANTIBIOTICS AND THAT THE SURGICAL GRAFT WILL REMAIN IMPLANTED. THE HEALTHCARE PROVIDER (HCP) WILL CONTINUE TO OBSERVE THE PATIENT'S SYMPTOMS. THE PATIENT IS REPORTEDLY STABLE.

    Patient problems: Unspecified Infection

    MAUDE report 9868458 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page